WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife News Network.

Hollyweed Launches Delta 8 Flower: Raises the Standards of the Hemp Industry

GLENDALE - Hollyweed, an emerging cannabis beauty and holistic company, has launched its line of products that may help Americans to keep up with their mental, spiritual, emotional and holistic fitness. 

Hollyweed has emerged as the leading company that manufactures cannabinoid and hemp products ever since the Californian Government lifted the ban on cannabis. The famous plant advocate and Multimedia artist Zach Fernandez played an essential role in the company's setup as he changed the famous Hollywood logo to the Hollyweed sign on New Year’s Eve in 2017.

The company was founded with the help of experts in the CBD field with the agenda of building people's health by keeping in mind the six wellness factors, i.e., spiritual, emotional, intellectual, environmental, physical and social. The team focuses on integrating the medical knowledge related to the CBD industry to promote the transparent and proper use of the Cannabinoid.  

The company's Chief Executive Officer, Renee Gagnon, showed exemplary enthusiasm during the launch of their Delta 8 Segment. He added, "We're thrilled to announce the launch of the new 8 products of our company that have been specially formulated to help people interested in CBD consumption try the products under the special dosage mentioned. The products would help the users enhance their knowledge regarding the CBD products as each product is mixed with the Delta 8 strain that makes the blend unique."

Here are the launched products of the Delta 8 THC range: 

Delta 8 Hemp Flowers ZKittles: 

This product is formulated with the best Hemp flowers. The strain used in the making is exceptionally delicious and beneficial and makes you feel euphoric after a long tiring day. The product is priced at $39.95- $69.95 for a 3.5-gram jar. 

e-mail icon
Continue reading

What Is CBDA And How Does It Help The Human Body?

Researchers believe that CBDA could be the next big medication for treating and maintaining overall mental and physical well-being.

Cannabidiolic acid (CBDA) is a minor cannabinoid with significant medicinal promise. Recent research suggests that CBDA could be an alternative treatment for managing or curing inflammation, anxiety, cancer, and seizures. The therapeutic potential of CBDA is the newest discovery of cannabinoid-based drugs.

Introduction to CBDA

Although research is still in the infant stage, researchers believe that CBDA could be the next big medication for treating and maintaining overall mental and physical well-being. Many cannabis-based scientists are optimistic that CBDA would reduce the need for conventional drugs with long-term side effects.

CBDA is mainly found in cannabis plant material. Like other major and minor cannabinoids, it reacts with the body’s endocannabinoid system and receptors in the central nervous system and immune system.

This less-famous cannabinoid exists as cannabigerolic acid (CBGA) before it is converted to its true form. The mother cannabinoid CBGA is not only a precursor to CBDA, but also to Tetrahydrocannabinolic (THCA) and Cannabicheomenic acid (CBCA)

Conversion of CBGA to CBDA

CBGA is converted into CBDA by an enzymatic process. Once formed, it remains this way until the decarboxylation process takes place. Decarboxylation is the conversion of acidic cannabinoids to their decarboxylated forms. CBDA is converted to CBD, THCA to THC, and CBCA to CBC. When cannabis is heated, the decarboxylation process takes place. Cannabinoids’ molecular structure changes when they are heated, dried, or treated. The method alters the substance’s chemical structure by removing one acidic carboxyl group.

While certain cannabis plants have been cultivated to contain balanced quantities of CBDA and THCA, CBDA is often only found in very small concentrations in cannabis plants. Mainly hemp plants are well-known for having significant levels of CBDA and traces of THCA.

e-mail icon
Continue reading

Where Do Most Physicians Turn To For Cannabis Education?

Researchers behind a recent survey were surprised to find that physicians’ level of knowledge of medical cannabis did not vary between states.

A recent survey has revealed that 71% of physicians affiliated with the Society of Cannabis Clinicians learned about medical cannabis from conferences. Only 1 participant out of 37 participants reported having learned about medical cannabis from medical school.

This survey confirms that cannabis education is not available in mainstream medical schools at either undergraduate or graduate levels, an issue that has been highlighted by the cannabis community on countless occasions. However, a majority of the physicians reported being content with the amount of cannabis information that is available to support physicians prescribing medical cannabis.

The aim of the survey was to investigate the knowledge level and source of knowledge of Prescribing Physicians in California as well as other states. Because California was the first state to legalize cannabis, the researchers assumed that physicians in this state would be more knowledgeable about cannabis. Surprisingly, this didn’t emerge as true from the survey.

The survey forms were sent out electronically to members of the society. Only physicians were eligible for the study and participation was purely on a voluntary basis with no incentives offered. A total of 133 members were eligible for the survey and 45 participated. Here are a few key findings that were highlighted by the survey:

71% of the participating physicians obtained most of their cannabis knowledge from conferencesOver 50% of physicians reported being satisfied with the medical cannabis information that is availableOver 75% had sufficient knowledge of cannabinoids and the endocannabinoid system

The researchers were surprised to find that physicians’ level of knowledge of medical cannabis did not vary between states. Physicians in California were not more knowledgeable as compared to physicians from others states, in spite of the fact that California has the oldest medical marijuana program.

Rate this article: 
Select ratingGive Where Do Most Physicians Turn To For Cannabis Education? 1/5Give Where Do Most Physicians Turn To For Cannabis Education? 2/5Give Where Do Most Physicians Turn To For Cannabis Education? 3/5Give Where Do Most Physicians Turn To For Cannabis Education? 4/5Give Where Do Most Physicians Turn To For Cannabis Education? 5/5
Authored By: 
Regional Marijuana News: 

e-mail icon

Fargo house will research Hemp Construction Material

The two small houses are going up on the back half of a lot just off a busy street, not far from downtown Fargo.

"These homes are identical in blueprint, they're 13 by 23, with 12 foot ceilings, there's a loft in each of them," explains Grassroots Development president Justin Berg, the man behind this one-of-a-kind construction and research project.

One of the houses is built with a traditional wood frame, fiberglass insulation and covered with that shiny white house wrap material. Walls are build using hemp hurd, or the inner woody part of the hemp plant mixed with lime and water, then sealed with plaster. A second house a few feet away also has a wood frame but the walls are filled with 12 inches of hempcrete, giving it a brown, textured look inside and out.

The raw material is called hurd. It’s the inner woody core of the hemp plant, chipped into small pieces. The hurd is mixed with a lime binder and water. "And you blend the mixture to a consistency, a nice sort of chicken salad — is our joke —consistency,” said Grassroots Development sustainability consultant Sydney Glup. “And we hand packed, physically hand packed, this entire house."

 

They were guided through the process by Bismarck, ND based Homeland Hempcrete, but the process was easy to learn said Glup, just a lot of work schlepping buckets of the material, dumping it into forms and packing it so the walls would be even after the forms were removed. The hempcrete walls need to cure for six weeks before they are covered inside and out with a finish layer of plaster.

e-mail icon
Continue reading

The Importance of evaporation in CBD extraction

Functional health and medicinal products containing CBD (cannabidiol) are growing in popularity, and the UK market is now worth £690 million a year according to trade association ACI, making it the second biggest market in the world after the United States. However traditional extraction processes do not always capitalise on the latest evaporation technology.

In fact, current growth in the market is exceeding even industry predictions, and has been estimated that with suitable policy support, the European market for legal cannabis products could be worth a massive €3.2 billion by 2025.

What is CBD?

CBD is a chemical extracted from hemp and marijuana plants, and while it an active ingredient in the cannabis drug, it does not cause the psychoactive effects associated with THC which is also found in the plants. Although medical studies are inconclusive, some of the claimed benefits of CBD include reducing inflammation, improving relaxation and focus, and slow down digestion. As such, it is often used to treat issues such as anxiety and insomnia, as well as some types of seizure and some digestive complaints.

How is CBD extracted?

There are a number of different techniques for extracting the CBD from the hemp plant, although most of these require the use of solvents which are effective at separating the CBD from other chemical compounds found in the plant. Once the CBD has been extracted, the solvent is evaporated off leaving pure CBD oil.

e-mail icon
Continue reading

Tennessee’s First Cannabis Restaurant set for Grand Opening

 Tennessee’s first cannabis restaurant — “Buds & Brews” — will officially open its doors in Germantown. 

The bar and restaurant serves elevated classic American dishes, and if you wish, with a side of special sauce.

“You can get chicken tenders and then you can order some THC ranch,” said Mike Solomon part owner of Buds & Brews. 

The secret here is in the sauce. 

“What is infused is the condiments. We have the 25 most common used condiments from ketchup, honey mustard, ranch dressing, steak sauce,” Solomon went on to explain.  

Legal, hemp-derived THC-infused condiments, desserts and mocktails are what make Buds & Brews a one-of-a-kind high.

e-mail icon
Continue reading

NWT RCMP deploys new roadside screening device for THC

 

Results in as little as 15 minutes.

Officers with the Northwest Territories RCMP have a new tool to determine if drivers are over the legal limit for cannabis.

The police service has now deployed the new roadside screening devices for THC across the territory, the NWT RCMP notes in a July 26 statement.

Conducted similarly to roadside alcohol tests, the RCMP reports the devices are used to take an oral fluid sample and can be completed in about 15 minutes. The sample will show whether or not the driver in question is over the legal limit.

The federal government notes that testing at or over two nanograms (ng), but under 5 ng, of THC per milliliter (ml) of blood, is a straight summary conviction offence punishable by a maximum fine of $1,000.

If a driver is convicted of a hybrid offence — either at or over 5 ng of THC per ml of blood or at or over 2.5 ng of THC per ml of blood combined with 50 mg of alcohol per 100 ml of blood — carries mandatory minimum penalties of $1,000 fine for a first offence, 30 days imprisonment for a second offence and 120 days imprisonment for a third offence.

e-mail icon
Continue reading

Doctors of Cannabis now offers medical marijuana card services in New York

Doctors of Cannabis is expanding their online medical marijuana certification services to the State of New York.

Doctors of Cannabis, renowned online providers of medical marijuana cards, has announced they are now offering medical marijuana certification services in New York. This expansion comes as good news to people throughout the Empire State struggling with certain medical conditions. The move gives millions of New Yorkers an opportunity to connect with medical marijuana professions and successfully gain access to medical marijuana dispensaries throughout the state.

"As a company whose core mission is providing quality care for patients across America, we couldn't be more excited to serve the good people of New York," said Dr. Erick Kaufman, MD, Medical Director of Doctors of Cannabis.

"Fact is, there are many people in the state who are truly in need of the numerous benefits associated with cannabis."

Patients who obtain a medical marijuana card online through Doctors of Cannabis will be given access to a licensed New York medical marijuana doctor. If approved, patients will receive a single ID from a secured online portal they can use in medical marijuana dispensaries within the state. After certification is complete, patients can easily register with the New York State Health Department to obtain an official plastic medical marijuana card from the comfort of their own home or office.

"Qualifying conditions for medical marijuana cards have typically been stricter in New York versus some other states," continued Dr. Kaufman.

e-mail icon
Continue reading

Green Scientific Labs launches new, proprietary Laboratory Information Management System (LIMS) that better manages cannabis and hemp testing process

Green Scientific Labs Holdings Inc. ("Green Scientific Labs" or the "Company"), leading multi-state provider of innovative cannabis and hemp testing technologies and methods, has launched its new laboratory information management system (LIMS) for immediate use across all its laboratory operations.

The company's proprietary LIMS technology contains a robust set of cutting-edge features including Artificial Intelligence to ensure compliance with state regulations on COAs, real-time turnaround time (TAT) tracking to identify bottlenecks and to ensure industry-leading testing times, digital batch downloading, and real time audit logs that compile a record of events and changes within the software. 

"There is a huge tech component to GSL's testing process that sets us apart from other testing labs in the industry. The LIMS that we built and used during the first three years of operations helped us service more than 1000 clients," said Michael Richmond, Chairman of Green Scientific Labs.

"In order to take Green Scientific Labs to the next level, support our rapid expansion, maintain turnaround times, and future proof ourselves for eventual FDA style regulations, we needed to take everything we learned and create something special. That's exactly what we did."

The custom-designed software built for the cannabis industry contains a host of new features:

Complete digitization of batch records, robust audit logging, instant verification of quality control samples, and automatic assignment of qualifiers based on state regulationsThe ability to create custom client packages, create or update quality control target values, and define rules on a state-by-state basisBetter efficiency without reliance on outside development provides the ability to build new labs more quickly than the competition

"Successful cannabis laboratories must be able to keep up with continuously evolving regulations and requirements without sacrificing quality, consistency, or accuracy," said Dr. Kristofer Marsh, Chief Scientific Officer of Green Scientific Labs.

e-mail icon
Continue reading

Jenny's Rose connects with LEAF411 member network to offer cannabis customers no cost, live nurse consultations for safe consumption

Jenny's Rose, an innovation and mission driven cannabinoid technology company with unique products backed by 4 USPTO patents, is pleased to become a supporting member of LEAF411, a non-profit live nurse hotline and community education organization. LEAF411 offers businesses the opportunity to provide no cost, live access to cannabis trained healthcare professionals and licensed nurses that provide customers guidance on safe use for both cannabis and hemp products.

"With the endless possibilities that the cannabis plant offers, having trained nurses available to safely coach customers on cannabis use, for no cost, helps to provide more acts of kindness on the Jenny's Rose mission to unlock the full potential of the plant and heal modern society. Our company is mindfully taking strides to compassionately care for our customers in the best and most innovative ways possible." Mentions Jimmy Castillo, Founder and Chief Science Officer of Jenny's Rose.

"Now more than ever, we need as many trustworthy resources for quality products as possible.," said Katherine Golden, a Registered Nurse and Executive Director of Leaf411.

"Jenny's Rose is a brand that is focused on providing a superior product line with a unique patented extraction method and is dedicated to stellar customer service. We are thrilled to have them on board as a pledge member and look forward to sharing their brand with consumers across the country"

Nurse consultations are currently offered by LEAF411 to the general public through web-based scheduling via leaf411.org or a caller based hotline 844-LEAF411 (844-532-3411). Through membership, Jenny's Rose customers and recipients will be provided a unique code to access LEAF411 healthcare professional and licensed nurses entirely free. LEAF411 also provides additional educational resources on medicinal cannabis, leading cannabinoid research study library, and overall greater access to affordable healthcare information.

e-mail icon
Continue reading

Cannabis telemedicine launches in Montana

Cannabis telemedicine is now a reality for folks in Montana thanks to a platform called NuggMD, already available in several states.

Telemedicine is a modern-day solution to healthcare problems for those in rural parts of the world, and now cannabis telemedicine also exists. Folks in Montana now have access to a platform called NuggMD that connects state licensed medical marijuana doctors to patients virtually. 

NuggMD, an already-established medical cannabis telemedicine platform, is launching its service in Montana. People who wish to be patients simply have to cough up the barrier of entry of $129 to be able to use the service. The platform is already being used by doctors and patients in California, Connecticut, Illinois, Iowa, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, and Virginia.

Despite its rural population, Montana is doing well when it comes to legal cannabis. They made record sales in June of over $17.2 million spent on recreational pot and over $7 million spent on medical cannabis, totaling almost $25 million in cannabis sales just for the month. The total for the year so far is $148 million. The highest cannabis sales are in Yellowstone County, which hit $4.1 million in June, 32% of those being recreational. On opening weekend of legal cannabis sales in the state, the total was already at $1.5 million.

“Yellowstone’s success makes it obvious that cannabis has been a huge boon for the tourist industry in Montana,” says Alex Milligan, CMO and co-founder of NuggMD.

“But the medical market is still running strong in the state because the program provides powerful advantages for Montana patients.”

e-mail icon
Continue reading

Confused about cannabis and DUI laws? A new interactive map clarifies.

The National Alliance to Stop Impaired Driving (NASID) has been around for nearly a year now, since its inauguration in July 2021. The organization is run by Responsibility.org and aims to eliminate all forms of impaired driving by achieving DUI system reform, promoting awareness, and enhancing DUI detection and data.

More importantly, NASID is trying to deploy various technologies to fight all forms of impaired driving. The most recent was released in late March this year, which is a user-friendly online tool aimed at helping drivers identify what they can or not do to ensure that they do not get behind the wheel while impaired.

It saves a great deal of time

The tool is designed with the hope that it will help drivers, road safety advocates, and prosecutors navigate the cannabis DUI easily. According to NASID director Darrin Grondel, road safety experts, prosecutors, and lawyers had to spend hours going through different databases, legal codes on a state and federal level, and countless resources on the internet to understand cannabis DUI statutes for a single state.

With the new tool, spending hours is a thing of the past. A user can get a snapshot of all statutes governing cannabis and DUI for any state in a few clicks. According to the tool’s designers, the goal was to solve the problem of constantly changing cannabis and impaired driving laws that can vary widely, making getting on top of the cannabis DUI legal landscape an elusive task for regulators, safety advocates, and other entities.

The tool is designed to provide an overview of state-specific laws. It is also linked to other resources that help users get detailed information on the following:

e-mail icon
Continue reading

Small cannabis farmers join forces to create a crypto-exclusive cannabis community, Emerald Road, to compete against conglomerates

A group of California cannabis farmers, led by legacy farmer and entrepreneur Justin Calvino, are coming together to build Emerald Road, a crypto-exclusive digital cannabis community. The advanced e-commerce platform will connect farmers directly with customers through a suite of purchasing and marketing tools, content and education, and community-building experiences, all powered on the blockchain. Designed as a virtual bazaar-like marketplace, Emerald Road will allow consumers to connect with, learn from, virtually visit, and purchase directly from farms.

"Emerald Road is about solving a problem and that solution just happens to be Web3," according to Calvino.

"Legacy platforms are not embracing emerging technologies and currently, there is no central hub for canna-culture and canna-curious consumers to connect, socialize, learn, transact, and be entertained, not to mention the restrictions on cannabis advertising. In addition, small farmers don't have the capital to market themselves on a broad scale like the bigger companies do. Emerald Road is the solution for all of those problems."

The more popular cannabis platforms are simply one-way communications, providing education and purchasing options for users. Emerald Road will let users actually interact with brands and other members to ask questions, take virtual farm tours, obtain exclusive products, participate in member-only experiences, and buy discounted products. Membership to Emerald Road is free for legacy members.

When launched in Q3 2022, the Emerald Road Utility Token will be used to purchase goods, services, and experiences throughout the Emerald Road ecosystem. A next-generation wallet will facilitate consumer and business transactions, allowing for seamless transfers from fiat currency to the Emerald Road Token and back again.

e-mail icon
Continue reading

AM LLC launches AM Bioscience to address cannabis safety

A new analysis of employee turnover in cannabis retail includes input from workers in Alberta, Ontario, British Columbia and Saskatchewan.

AM LLC (AM), a public health solutions and health IT firm, announced the launch of their new service line, AM Bioscience℠. Designed to help state and local governments achieve cannabis regulatory requirements and consumer health protection goals, AM Bioscience service offerings include laboratory testing, compliance and regulatory support, research development and peer review, market analysis, and social equity programming.

"AM remains committed to working with government agencies to safeguard public health as cannabis legalization continues to expand nationwide," said Dan Gabriel, CEO.

"AM Bioscience builds upon our network of talented researchers and top experts, enhancing AM's capabilities to help our clients navigate compliance complexities, ensure cannabis safety, and proactively protect the health of our communities."

While there are endless opportunities to license, tax, and regulate medical and adult-use cannabis, responsible regulatory strategy must ensure consumer safety through comprehensive quality assurance. Recognizing that successful implementation requires input from a wide range of specialties, AM assembled a multidisciplinary team of subject matter experts adept at addressing the intricacies of cannabis regulatory frameworks. With AM Bioscience, government agencies gain access to the full complement of cannabis regulatory services from some of the nation's top cannabis researchers, laboratory directors, policy analysts, and public health professionals.

Rate this article: 
Select ratingGive AM LLC launches AM Bioscience to address cannabis safety 1/5Give AM LLC launches AM Bioscience to address cannabis safety 2/5Give AM LLC launches AM Bioscience to address cannabis safety 3/5Give AM LLC launches AM Bioscience to address cannabis safety 4/5Give AM LLC launches AM Bioscience to address cannabis safety 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

Medical Marijuana, Inc. subsidiary HempMeds® Brasil launches health & wellness podcast; secures features in top Brazil lifestyle publications

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil has established a new health and wellness-focused podcast PodioCast and, as a result, has been featured in several top news publications in Brazil such as Globo’s Galileu Magazine (pictured below), SportLife, and the Desobediência Produtiva podcast. PodioCast is hosted by actress and presenter Rachel Apollonio, HempMeds® Brasil Executive Director Matheus Patelli, and seasoned journalist and HempMeds® Marketing Specialist Marcus Bruno. Each episode features interviews with athletes and medical professionals to talk about the wellness challenges and routines of top athletes and active consumers.

“The mission for our podcast is to help break the stigma of CBD and cannabis and educate people how they can incorporate it into their lives,” said HempMeds® Brasil Executive Director Matheus Patelli.

“We’ve already been able to get exclusive interviews with a variety of influential X-Games winners, MMA and boxing world champions, and other Olympic medalists and these articles have been a great help for us to promote the podcast.”

In addition to the podcast, these articles talk about how the World Anti-Doping Agency (WADA) removed CBD from its list of banned substances in 2018 and since then, more athletes, both professional and amateur, in Brazil have started to use CBD products, such as those offered by HempMeds®.

They also highlight how HempMeds® has been dedicated to educating patients and doctors on cannabidiol (CBD) since the inception of the company. HempMeds® education initiatives include online academic resources, in-person, and virtual medical training courses to train physicians about cannabinoid treatments and discuss the principles of the human endocannabinoid system, and sponsorships of global CBD and condition-specific seminars aimed at helping patients with legal guidelines, finding doctors, and financial support.

e-mail icon
Continue reading

Cannabix Technologies participates in new study with marijuana breathalyzer technology – Southern United States

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company is participating in a new comprehensive multi-analysis study of subjects under the influence of marijuana. The new study will work along side toxicologists and law enforcement officers in the southern United States. In late June, the Company participated in the first of three testing sessions that are expected to be held over the summer. The Company has been coordinating for several months on its participation in this study with senior administrators. The study will test subjects under the influence of marijuana alongside several conventional drug screening methods (blood, oral fluid etc.), in conjunction with the use of Cannabix’s proprietary breath capture and marijuana detection equipment (described below). Further, details of the study will be available in due course when disclosure approvals are granted to the Company.

Cannabix has granted use of its Breath Collection Unit and newly developed laboratory “MS Breath Sampler” equipment to this important new research study focused on the detection of marijuana impairment in human subjects. The Company is building upon recent independent study results that showed excellent correlation between blood plasma THC and breath samples collected and analyzed with Cannabix equipment (see news release dated May 9, 2022). The Company’s handheld Breath Collection Unit and newly developed laboratory “MS Breath Sampler” were used to detect the low volatile THC samples from breath with analysis completed without sample preparation and the results confirmed by conventional mass spectrometry.

 

New Cannabix Breath Collection Unit (BCU)

This kind of study underway in southern United States will provide an important launch point for Cannabix devices in terms of a law enforcement and toxicology audience. Cannabix is using its marijuana breathalyzer technology to detect ∆9-tetrahydrocannabinol (“THC”) - the psychoactive component of marijuana that causes impairment, in breath. Breath testing for THC would allow law enforcement to quickly and practically identify recent marijuana use that aligns with the timing window of impairment, unlike other technologies such as saliva or urine.

Currently, Cannabix is focussed on capturing and analyzing real-world breath data using its equipment. Company scientists are confirming these breath results against gold-standard techniques of mass spectrometry – the primary method that the toxicologist community, regulatory bodies and other stakeholders rely on routinely for analytical confirmation. The research study is an important opportunity to provide relevant real-world data for regulators and other experts seeking new ways to effectively screen for marijuana impairment. Cannabix will use most of the same hardware for its point of care (FAIMS based) detection system. The Company expects to expand such testing as it prioritizes various requests.

According to the NHTSA report to congress (2017) THC in blood drops rapidly after cessation of smoking. In contrast to alcohol, which is metabolized at a relatively steady rate, THC is metabolized at an exponentially declining rate where the THC blood level first drops rapidly, followed by a slower decline as lower THC levels are reached. Within 30 minutes of smoking THC level can decline 80 – 90 percent from its peak level, while levels of metabolite increase (which can be identified using the Cannabix MS Breath Sampler). After a few hours, only low or no THC can be detected in blood. Confirmation of drug presence as quickly as possible after the time of a law enforcement stop is paramount to increase the chance of convictions for recency of use in drugged driving. Use of Cannabix equipment can help reduce the time to confirm drug presence with easy to collect breath samples using breath analysis techniques that law enforcement officers are already familiar with.

Rate this article: 
Select ratingGive Cannabix Technologies participates in new study with marijuana breathalyzer technology – Southern United States 1/5Give Cannabix Technologies participates in new study with marijuana breathalyzer technology – Southern United States 2/5Give Cannabix Technologies participates in new study with marijuana breathalyzer technology – Southern United States 3/5Give Cannabix Technologies participates in new study with marijuana breathalyzer technology – Southern United States 4/5Give Cannabix Technologies participates in new study with marijuana breathalyzer technology – Southern United States 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

Cannatrek secures debt funding for Victorian cannabis venture

Australia’s Cannatrek says it will be able to accelerate construction of its medical cannabis facility near Shepparton in Victoria after securing debt funding.

Cannatrek secured planning permission for the facility in 2019 and the following year the project was awarded Major Project Status from the Federal Government. Construction was to kick off in 2020, but then COVID happened.  It wasn’t until around March this year construction was finally able to commence.

Then in April, Victoria’s State Government announced funding for the facility from its Regional Jobs Fund.

Early this month, Cannatrek announce  the Commonwealth Bank of Australia (CBA) has provided the company an approved debt facility – which is a vote of confidence in the project and the company.

“To have a Tier 1 bank in the CBA supporting our projects in Shepparton is a tremendously positive sign of growth for our industry and the general health sector,” said Cannatrek CFO Brett Schwarz.

“It should give the Australian public confidence we are moving forward with a growth strategy to boost our local economy and deliver quality of life therapies to many Australians.”

e-mail icon
Continue reading

Cannabis in the esports community

OpTic HECZ takes us into the heart of esports, and challenges corporations such as Facebook, Google, and TikTok to end the digital war on cannabis.

My name is OpTic HECZ and I had the honor of joining the cannabis industry by way of professional esports and building brands on the internet. Big shout out to my boy Jon Cappetta for inviting me to be a contributor to WEIRDOS and to share reflections from my journey. I know you all will be absolutely shocked to learn that there has always been a vibrant cannabis culture behind the scenes of gaming and esports, so my goal when joining the cannabis industry was to take the lessons I learned building OpTic Gaming and introduce them to a plant I love and traditional cannabis culture I feel naturally connect to.

Esports and cannabis cultures were both born on the edges of society and we’re still battling stigmas despite growing into multi-billion dollar global industries. While gamers never had to face the War on Drugs, many of us took huge personal risks and made extreme sacrifices to help build esports into what it is today. My wife and family were dangerously supportive when I left my corporate job in early 2009 to focus on becoming a full-time YouTube content creator, and after a year of telling them that “this is going to work out,” my first check was a hilarious 16 cents from monetizing Call of Duty montage videos. I may not have lived in tent on a hill in Humboldt County, but you better believe that back in June 2013 when we launched the first OpTic House, my wife and I were called crazy when we told our family that we would be moving to her parents’ basement to allow the players to move in to our current home and make one of the first YouTube content houses a reality.

Despite the risks and labels, cannabis OGs know the important lesson that the diehard esports community learned through our commitment: it’s what we did and stood for when everyone thought we were weirdos, before all the corporate investors rushed in, that will forever resonate in our respective cultures.

For esports, 6050 Russell Drive showed the world that OpTic Gaming, operating out of a cul-de-sac in Hoffman Estates, Illinois, could have a larger social media presence then all of Chicago’s historic sports franchises aside from the great Chicago Bulls (and that’s only because they had GOD in uniform during the 90s). That revelation drove many billionaire owners from traditional sports to quickly buy esports teams—we were one of the lucky teams that were paired up with incredible investors, but many other investors came into our industry with as much respect for the culture that made OpTic and esports popular as Chad has for growing and selling good weed.

So I came to cannabis knowing what it’s like to create something from a place of passion and I have seen firsthand the interests of big money trying to get their piece of something new. In 2017, an ownership group made me an offer I couldn’t refuse and I was happy to sell OpTic in hopes of expediting our growth as an elite professional esports franchise. But then things happened, people happened and business happened and I ultimately decided to buy back OpTic in 2020. The journey that led me to buying back OpTic taught me a very important lesson relevant to the cannabis industry today: when you put your heart and soul into something, the authentic relationship that you develop with supporters building that brand can never truly be bought or sold.

e-mail icon
Continue reading

Surfside announces general availability of cannabis advertising platform in Canada

 

Canada-based dispensaries and brands can now use Surfside's leading cannabis advertising platform to grow their business

Surfside Solutions Inc. ("Surfside"), an end-to-end marketing technology that aggregates first-party data across all customer touchpoints, today announced the general availability of the Surfside Platform to Canadian dispensaries and brands. By combining the power of a customer data platform (CDP) and a demand side platform (DSP), Surfside provides an all-in-one solution for cannabis businesses looking to activate customer data by advertising to new and existing customers across websites and mobile apps.

"Surfside has been a great advertising partner for our business," says Will Alexander, head of marketing at Burb, a British Columbia-based dispensary chain and cannabis brand.

"By giving us the ability to advertise to local cannabis consumers with digital ads and track the results for both ecommerce and in-store sales, Surfside helps make sure that every ad dollar we spend is helping us grow."

With the Surfside Platform, cannabis businesses can:

Advertise to cannabis consumers across 1M+ websites and mobile apps.Reach custom and lookalike audiences based on 25K+ behavioral attributes.Track in-store and ecommerce results from ad campaigns in a powerful performance dashboard.

"We have been building our presence and capabilities in Canada through a series of partnerships and campaigns over the last twelve months and we can't wait to start helping more Canadian clients grow as we invest more heavily into this important market," says Travis Scadron, VP of Business Development at Surfside.

Rate this article: 
Select ratingGive Surfside announces general availability of cannabis advertising platform in Canada 1/5Give Surfside announces general availability of cannabis advertising platform in Canada 2/5Give Surfside announces general availability of cannabis advertising platform in Canada 3/5Give Surfside announces general availability of cannabis advertising platform in Canada 4/5Give Surfside announces general availability of cannabis advertising platform in Canada 5/5
Authored By: 
Regional Marijuana News: 

e-mail icon

Aphios® Pharma LLC to host webinar on the business of cannabis as a pharmaceutical medicine on Thursday, July 14, 2022 at 12:00 pm EST

We are pleased to announce that Aphios® Pharma LLC will host a live webinar followed by Q&A on the business of cannabis as a pharmaceutical medicine.

This webinar will cover the business of cannabis as a pharmaceutical medicine, touching on the business of cannabis in recreational and medical use. We will show you our competitors and competitive advantages in the pharmaceutical marketplace. We will present estimates of the total and accessible marketplaces for our first-generation products targeting generalized social anxiety disorder (GSAD), chemotherapy induced peripheral neuropathic pain (CIPNP), opioid use disorder (OUD), and pain and spasticity associated with Multiple Sclerosis (PSAMS). We will then layout our product development plans and commercialization strategies for each identified segment of our market. The webinar will close with investment, financing and exit strategies.

Join Aphios® Pharma founder and CEO Dr. Trevor P. Castor, along with guests Dr. Val R. Livada, Business Advisor and Controller Catherine Prillo, on July 14, 2022, from 12 pm to 12:45 pm EST, for a discussion on the financial aspects of cannabis as a medicine and the drug-delivery nanotechnologies that make cannabis more effective.

Rate this article: 
Select ratingGive Aphios® Pharma LLC to host webinar on the business of cannabis as a pharmaceutical medicine on Thursday, July 14, 2022 at 12:00 pm EST 1/5Give Aphios® Pharma LLC to host webinar on the business of cannabis as a pharmaceutical medicine on Thursday, July 14, 2022 at 12:00 pm EST 2/5Give Aphios® Pharma LLC to host webinar on the business of cannabis as a pharmaceutical medicine on Thursday, July 14, 2022 at 12:00 pm EST 3/5Give Aphios® Pharma LLC to host webinar on the business of cannabis as a pharmaceutical medicine on Thursday, July 14, 2022 at 12:00 pm EST 4/5Give Aphios® Pharma LLC to host webinar on the business of cannabis as a pharmaceutical medicine on Thursday, July 14, 2022 at 12:00 pm EST 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

WeedLife.com